By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aegerion Pharmaceuticals, Inc. 

101 Main Street
Suite 1850
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-500-7867 Fax: 908-541-1155




Company News
Aegerion (AEGR) Announces First Quarter 2016 Financial Results 5/17/2016 8:47:01 AM
Aegerion (AEGR) Observes Rare Disease Day 2/29/2016 7:52:16 AM
Aegerion (AEGR) Announces Fourth Quarter And Full Year 2015 Financial Results 2/26/2016 8:02:15 AM
Facing Tough Competition from Regeneron (REGN) and Amgen (AMGN), Aegerion (AEGR) Slashes 25% of Workforce 2/11/2016 6:06:55 AM
Aegerion (AEGR) Release: JUXTAPID (Lomitapide) Capsules Available On The Régie De l'Assurance Maladie Du Québec (RAMQ) For The Treatment Of Homozygous Familial Hypercholesterolemia (HoFH) 11/20/2015 10:50:26 AM
Aegerion (AEGR) Announces Presentation At The Leerink Rare Disease Roundtable 9/24/2015 9:48:54 AM
Aegerion (AEGR) Observes Familial Hypercholesterolemia Awareness Day 9/24/2015 9:39:08 AM
Donald K. Stern, Esq. Appointed To Aegerion (AEGR)' Board Of Directors 9/18/2015 9:26:48 AM
Aegerion (AEGR) Grants Stock Options Under Inducement Program 9/15/2015 7:54:36 AM
Ironwood (IRWD), Aegerion (AEGR), and MannKind Corporation (MNKD) Face Stiff Headwinds: Analyst 8/17/2015 7:14:37 AM